Documentdetail
ID kaart

doi:10.1007/s00415-023-11802-2...

Auteur
Miscioscia, Alessandro Puthenparampil, Marco Blasi, Lorenzo Rinaldi, Francesca Perini, Paola Sorarù, Gianni Gallo, Paolo
Langue
en
Editor

Springer

Categorie

Medicine & Public Health

Jaar

2023

vermelding datum

14-06-2023

Trefwoorden
optical coherence tomography amyotrophic lateral sclerosis kennedy’s disease motoneuron disease neurodegeneration biomarker duration significantly clinical value als p = 0 prnfl diseases atrophy
Metriek

Beschrijving

Background To what extent retinal atrophy in neurodegenerative diseases reflects the severity and/or the chronicity of brain pathology or is a local independent phenomenon remains to be clarified.

Moreover, whether retinal atrophy has a clinical (diagnostic and prognostic) value in these diseases remains unclear.

Objective To add light on the pathological significance and clinical value of retinal atrophy in patients with amyotrophic lateral sclerosis (ALS) and Kennedy’s disease (KD).

Methods Thirty-five ALS, thirty-seven KD, and forty-nine age-matched healthy controls (HC) were included in a one-year longitudinal study.

Spectrum-domain optical coherence tomography (OCT) was performed at study entry (T0) and after 12 months (T1).

Disease duration and functional rating scale (FRS) for ALS and KD patients were correlated to retinal thicknesses.

Results Compared to HC, peripapillary retinal nerve fiber layer (pRNFL) thickness was significantly thinner in both ALS (p = 0.034) and KD (p = 0.003).

pRNFL was thinner in KD compared to ALS, but the difference was not significant.

In KD, pRNFL atrophy significantly correlated with both disease severity (r = 0.296, p = 0.035) and disease duration (r = – 0.308, p = 0.013) while no significant correlation was found in ALS (disease severity: r = 0.147, p = 0.238; disease duration: r = – 0.093, p = 0.459).

During the follow-up, pRNFL thickness remained stable in KD while significantly decreased in ALS (p = 0.043).

Conclusions Our study provides evidence of retinal atrophy in both ALS and KD and suggests that retinal thinning is a primary local phenomenon in motoneuron diseases.

The clinical value of pRNFL atrophy in KD is worthy of further investigation.

Miscioscia, Alessandro,Puthenparampil, Marco,Blasi, Lorenzo,Rinaldi, Francesca,Perini, Paola,Sorarù, Gianni,Gallo, Paolo, 2023, Neurodegeneration in the retina of motoneuron diseases: a longitudinal study in amyotrophic lateral sclerosis and Kennedy’s disease, Springer

Document

Openen

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw